Objectives: To prospectively validate that the inability to decrease procalcitonin levels by
more than 80% between baseline and day 4 is associated with increased 28-day all-cause …

Objective The primary objective of this study was to determine the correlation between
procalcitonin values and illness severity by evaluating the degree of end organ dysfunction …

Introduction Close monitoring and repeated risk assessment of sepsis patients in the
intensive care unit (ICU) is important for decisions regarding care intensification or early …

This study explores the role of procalcitonin (PCT) in predicting the outcome of sepsis. In a
prospective multicentre observational investigation, blood was sampled within 24h of onset …

Background There is a growing use of procalcitonin (PCT) to facilitate the diagnosis and
management of severe sepsis. We investigated the impact of one to two PCT determinations …

Background Procalcitonin is useful for the diagnosis of sepsis but its prognostic value
regarding mortality is unclear. This prospective observational study was designed to study …

Procalcitonin (PCT) is an acute-phase reactant that has been used to diagnose and
potentially track the treatment of sepsis. Procalcitonin values rise initially as the infection sets …

Rationale: The role of procalcitonin (PCT), a widely used sepsis biomarker, in critically ill
patients with sepsis is undetermined. Objectives: To investigate the effect of a low PCT cut …

PURPOSE: The objective of this study is to define if early changes of procalcitonin (PCT)
may inform about prognosis and appropriateness of administered therapy in sepsis …

Objective: To determine whether procalcitonin is a reliable diagnostic and prognostic marker
in septic shock compared with nonseptic shock. Design: Prospective controlled trial. Setting …